Clinical Research Unit

Director: Dan Vogl, MD

The Clinical Research Unit (CRU) is an essential core resource that supports therapeutic clinical trials conducted by Abramson Cancer Center (ACC) investigators.

The specific objective of the core is to provide the necessary infrastructure to support adult therapeutic clinical trial research in the ACC. The CRU provides a full spectrum of services including protocol development, budget and financial analysis, regulatory affairs expertise, research nursing, and data management. As a centralized administrative unit, the CRU provides highly skilled research personnel to support the ACC clinical researchers who would not otherwise have the resources necessary to properly conduct clinical trials.


Dan Vogl, MD